✓
Open
27 May 2025
✓
Close
29 May 2025
3
Allotment
—
✓
Listing
Tue, Jun 3, 2025
Price Band
₹128 to ₹135
Issue Size
27,90,000 shares (agg. up to ₹38 Cr)
Lot Size
1,000 Shares
Listing Date
Tue, Jun 3, 2025
Latest GMP
₹0
Est. Gain
0%
✦ AI Insight
GMP Trend
03-06-2025₹0Est. ₹135+0%
02-06-2025₹0Est. ₹135+0%
01-06-2025₹0Est. ₹135+0%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 2.10x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 96.52 | 80.89 | 64.28 | 52.91 |
| Total Income | 69.69 | 80.29 | 67.26 | 30.17 |
| Profit After Tax | 4.10 | 3.81 | 0.67 | 0.25 |
| NET Worth | 17.28 | 11.97 | 8.16 | 7.49 |
| Reserves and Surplus | 9.56 | 4.37 | 4.16 | 3.49 |
| Total Borrowing | 49.48 | 42.40 | 35.99 | 29.52 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹165.65 (-0.21%) |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.39 (+3.04%) |
| Sat Kartar Shopping Ltd. | SME | ₹33.80 Cr | ₹81 | 14.87 | ₹161.55 | +99.44% | ₹126.60 (-2.62%) |
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹37.60 (-4.93%) |
| Medicamen Organics Ltd. | SME | ₹10.54 Cr | ₹34 | 30.53 | ₹144.70 | +325.59% | ₹22.90 (-0.43%) |
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,405.10 (-3.68%) |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,272.00 (-1.60%) |
| Akums Drugs & Pharmaceuticals Ltd. | Mainboard | ₹1,856.74 Cr | ₹679 | null | ₹796.25 | +17.27% | ₹664.95 (-2.60%) |
| Emcure Pharmaceuticals Ltd. | Mainboard | ₹1,952.03 Cr | ₹1008 | 34.55 | ₹1,359.15 | +34.84% | ₹1,783.20 (-1.07%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of expenses proposed to be incurred towards registration in Bolivia, South America | 1.29 |
| 2 | Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises | 5.23 |
| 3 | Advertising, marketing and brand building | 4.95 |
| 4 | Investment in procuring hardware and software | 0.68 |
| 5 | Funding of Working Capital Requirements | 19.75 |
| 6 | General Corporate Purposes | 1.99 |
| 7 | Issue Expenses | 3.77 |
| Total | 37.67 |
About Astonea Labs IPO
Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally. The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynecological issues, infections, and more. The company offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for pharmaceutical and cosmetic industries, meeting industry standards. The company engages in contract manufacturing of pharmaceutical and cosmetic products, markets its own brands "Glow Up" and "Regero," plans to launch "Avicel," and exports to countries like Iraq and Yemen. Produts and Offerings: Products under our own brands: The company markets “Glow Up” skincare and “Regero” pharma products, offering diverse affordable solutions. Products under contract manufacturing: The company provides pharmaceutical and cosmetic products under contract manufacturing, primarily for domestic and export markets. As of August 16, 2024, the company had 217 employees
Contact Details
Astonea Labs Ltd. AddressSCO 186-187, 2nd Floor, Cabin No.206Sector 8 C, Sector 8Chandigarh, Chandigarh, 1600099888302323cs@astonea.orgVisit Website